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Summary: Zinc concentration in erythrocytes is a suitable marker of peripheral tissue response to thyroid
hormones. Therefore, the determination of erythrocyte zinc concentration has become an important marker
for duration of preexisting hyperthyroidism in the clinical laboratory. We compared a new indirect erythrocyte
zinc determination method with a commonly used direct method in 42 euthyroid and 14 hyperthyroid subjects.
Zinc concentrations (median and range) obtained by direct and indirect methods were 172.8 (134.4 — 241.1)
and 176.8 (143-243.9) μιιιοΐ/ΐ erythrocytes in the euthyroid group and 117.1 (71-141.9) and 118.5 (73-137)
μπιοΐ/ΐ erythrocytes in the hyperthyroid group. Values measured by the indirect method were slightly higher
in both groups. Regression analysis showed a good correlation (r = 0.967, ρ = 0.0001). The influence of the
anticoagulants, potassium EDTA and heparin, on erythrocyte and plasma zinc values was studied, and zinc
concentrations in serum and plasma were compared. No statistically significant differences were found. Thus,
the indirect determination of erythrocyte zinc concentration is a simple and rapid technique well suited for
use in clinical laboratory work, yielding accurate and reliable results. For the indirect method reference
concentrations were established in a collective of 102 thyroid healthy subjects. An erythrocyte zinc concen-
tration of 176.3 ± 23.9 μπιοΐ/ΐ (mean + SD) was found with a cut-off limit of 138 μπιοΐ/ΐ to hyperthyroidism.
Introduction centration over the previous several weeks and
The interaction between thyroid function and zinc months (9, 10). For this reason it is possible to dif-
metabolism has long been a matter of investigation ferentiate short from the long duration hyperthyroid-
(1 -3). It is a well known fact that during hyperthy- ism by determination of the erythrocyte zinc concen-
roidism the zinc concentration in erythrocytes de- tration. Lao et al. (11) reported that determination of
creases and serum zinc is increased (4, 5). The reason erythrocyte zinc concentration makes it possible to
for the decreased erythrocyte zinc concentration is discriminate between preexisting hyperthyroidism and
inhibition of the synthesis of carbonic anhydrase-I transient hyperthyroidism in pregnancy due to hyper-
isoenzyme in erythrocytes by high thyroid hormone emesis gravidarum, and so facilitates the choice of
concentrations. The greatest amount of zinc in eryth- therapy.
rocytes is bound as a structural part of this enzyme Erythrocyte zinc concentration is commonly meas-
(6—8). Changes in erythrocyte zinc concentration, as ured directly: erythrocytes are separated from whole
a result of changes in thyroid function, take time to blood and the resulting pellet is analysed (10,12). The
develop because of the relatively long half-life of separation and washing procedures have to be per-
erythrocytes. Therefore, erythrocyte zinc concentra- formed immediately after venous puncture, and they
tion reflects the patient's mean thyroid hormone con- are labour intensive and time consuming. Indirect
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determination of erythrocyte zinc concentration by
measuring serum and whole blood zinc and calculat-
ing the concentration in erythrocytes according to
haematocrit values would be a suitable method for
routine laboratories.
The aim of this study was to check the comparability
of a direct and an indirect method for determining
erythrocyte zinc concentration in euthyroid as well as
hyperthyroid subjects, and to establish reference
ranges for thyroid healthy subjects. The influence of
several anticoagulants on erythrocyte and plasma zinc
concentration was studied.
Materials and Methods
Reagents
Zinc standards were prepared from a 1 g/1 zinc chloride refer-
ence solution .(Merck No 9953). Triton X 100 was purchased
from Serva. Chelex® resin from Bio Rad, zinc reference material
from Nycomed (whole blood; Lot. No. 906, target value 70.5
μηΊθΙ/1) and Merck (Qualitrol N® serum; Lot. No. 390, target
value 17.7 + 1.2 μηιοΐ/ΐ).
All reagents were of analytical grade. All solutions were made
with double distilled water.
Apparatus
All analyses for zinc were performed by flame atomic absorp-
tion spectrophotometry (Perkin Elmer 2380) with a zinc hollow
cathode lamp (213.9 nm), an air acetylene flame and instru-
mental conditions as described previously (13). Haematocrit,
haemoglobin (Hb) and erythrocyte count were determined on
a Sysmex Ε 5000 analyser.
Standards
Working standard solutions were prepared from the stock so-
lution mentioned above by diluting with double distilled water
to zinc concentrations of 15.3 and 30.6 μιηοΐ/ΐ. To solve matrix
problems for serum zinc determination, zinc standards were
prepared in zinc-free human serum matrix. We improved the
previously published zinc depletion (13, 14) by using Chelex®
ion exchanger instead of Dowex®. Chelex® resin can be used
directly, whereas Dowex® resin had to be washed several times
to remove excess acid. Chelex® resin (4.5 g) was weighed into
polypropylene tubes, then 6 ml of pooled human serum were
added to each tube and slowly mixed with a rotating mixer for
16 hours. The tubes containing serum and resin were stored at
+ 4 °C; they are stable for several months.
Zinc-free serum matrix and standard working solutions (15.3
and 30.6 umol/1) were mixed 1 :2 and diluted further with 3
aliquots of Triton X 100 (1 g/1). The blank was prepared by
diluting zinc-free serum matrix with Triton X 100 (1 g/1), (1 : 5).
Patient samples
Forty two euthyroid and 14 hyperthyroid subjects were included
in the study protocol. Thyroid function was checked by fT4,
fT3 and thyrotropin. The euthyroid subjects had been hospi-
talised for health checks. Hyperthyroid patients had immune-
hyperthyroidism (n = 8) or thyroid autonomy (n = 6). Fasting
blood samples were obtained in the morning and collected in
polypropylene syringes with and without potassium EDTA.
Syringes had been previously checked for trace metal contam-
ination.
Blood in syringes without additives was centrifuged after clot-
ting, and serum was transferred into new zinc-free polypropyl-
ene tubes and analysed for zinc concentration no later than the
next day. Blood in syringes anticoagulated with potassium
EDTA was used for measuring haematocrit, Hb, erythrocyte
count, zinc concentration in whole blood and in the erythrocyte
pellet.
Determination of zinc concentration
Direct method
Erythrocytes were separated from plasma no later than four
hours after venous puncture, as described elsewhere (3). Briefly,
after centrifugation of 100 μΐ EDTA blood, the buffy coat was
removed and the sediment erythrocytes were washed three times
with NaCl (154 mmol/1), then supplemented with Triton X 100
(1 g/1) to 100 μΐ and haemolysed in 1200 μΐ Triton X 100 (1 g/1)
(final total dilution 13-fold). Zinc concentration was expressed
in micromol per litre erythrocytes.
Indirect method
Whole blood in twentyfive-fold dilution and serum in five-fold
dilution with Triton X 100 (1 g/1) were subjected to analysis.
Values were calculated with the formula:
Zn (erythrocytes) [μπιοΐ/ΐ]
_ Zn (whole blood) [μπιοΐ/ΐ]
Haematocrit
__ Zn (serum) [μιηοΐ/l] (1.00 - haematocrit)
Haematocrit
Additionally, fasting blood samples were obtained from 10
persons and collected in polypropylene syringes anticoagulated
with potassium EDTA, or with heparin, and in syringes without
additives. We tested the influence of different anticoagulants
on erythrocyte zinc concentration and compared zinc concen-
trations in serum, heparinized plasma and EDTA plasma. Se-
rum and plasma were separated from cellular blood components
one hour after collection.
Reference values
Reference values were established on 102 thyroid healthy sub-
jects (43 men, 59 women) with a mean age of 56 ± 14 years.
Normal thyroid function was verified by normal function tests
(fT3, fT4, basal thyrotropin) and physical examination.
Statistical analysis
For statistical comparisons the non-parametric Wilcoxon signed
ranks test was used. Correlation between the two methods was
calculated by linear regression analysis. For normally distrib-
uted data, the mean and standard deviation (SD) were recorded.
For non-normally distributed data, the median and range were
recorded.
Results
'Imprecision studies
The intra-assay imprecisions for the direct and indi-
rect determination of erythrocyte zinc and serum zinc
concentration were obtained by analysing samples
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Tab. 1. Imprecision of direct and indirect method and serum zinc determination
Sample Mean
(μΓηο1/1)
SD(μηιοΐ/1) cv
Intrα-assay imprecision (n = 10)
Indirect method Blood (low)
(μιηοΐ/ΐ erythrocytes) Blood (high)
Direct method Blood (low)
(μπιοΐ/ΐ erythrocytes) Blood (high)
Serum Serum (low)
(μιηοΐ/ΐ serum) Serum (high)
Inter-assay imprecision (day to day; η = 10)
Indirect method Blood
(μηιοΐ/ΐ erythrocates)
Direct method Blood
(μιηοΐ/ΐ erythrocytes)
Serum Serum
(μπιοΐ/ΐ serum)
109.3
218
115.4
247.5
12.7
22.2
186.6
188.2
12.7
1.7
3.9
1.1
5.7
0.2
0.6
9.6
10.6
0.5
1.6
1.8
1
2.3
1.6
2.8
5.2
5.6
4.1
from 6 different individuals in low and high concen-
tration ranges in ten replicates. Coefficients of vari-
ation (CV) ranged from 1 to 2.8% (see tab. 1).
For the determination of day-to-day imprecision, 3
samples from different individuals were analyzed on
10 successive days. For the direct method, ten aliquots
of whole blood were washed and the resulting pellets
frozen at — 20 °C until analysis. For the indirect de-
termination, whole blood and serum were frozen (10
aliquots of each) at — 20 °C until analysis. Variation
coefficients ranged between 4.1 and 5.6% (tab. 1).
Accuracy studies
For quality control of the zinc determination only
lyophilised reference material (whole blood and se-
rum) is commercially available. This material is there-
fore only suitable for checking the indirect method.
We analysed zinc concentrations in whole blood and
serum reference material, obtaining mean values of
70.2 μπιοΐ/ΐ erythrocytes and 17.7 μιηοΐ/ΐ serum with
CVs < 5% (n = 10 each), close to the target values
mentioned in the methods section.
To investigate the analytical recovery of zinc we added
zinc in two different amounts (50 and 100 μg respec-
tively) to samples from six different individuals with
previously determined zinc contents (10 replicates,
mean ± SD, see tab. 2). Zinc was added to the eryth-
rocyte pellet for the direct method and to whole blood
and serum for the indirect method. Mean analytical
recoveries of 99-101% with SDs < 2.3% were ob-
tained (see tab. 2).
Comparison of direct and indirect method
To examine differences between the two methods we
analysed the erythrocyte zinc concentrations of 42
euthyroid and 14 hyperthyroid individuals directly
Tab. 2. Mean analytical recovery (n = 10) for zinc added to whole blood samples, erythrocyte pellets and serum
Concentration*
before addition
Indirect method
(μηιοΐ/l erythrocytes)
Direct method
(μηιοΐ/l erythrocytes)
Serum
(μπιοΐ/ΐ serum)
Mean
168.1
173.3
194.8
209.4
12.7
15.5
SD
3.4
3.5
3.9
4.8
0.2
0.3
Amount
added
50
100
50
100
50
100
Recovery
Mean
100.9
100.6
100.2
101.3
99.2
100
SD
2.1
1.1
0.6
2.3
1.6
1.9
* Mean and SD (μηιοΙ/1) for samples from six different individuals analysed in ten replicates
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Fig. 1. Linear regression analysis of indirect versus direct eryth-
rocyte zinc determination method in euthyroid and hy-
perthyroid subjects (n = 56); r = 0.967, p = 0.0001,
y = 0.992x + 305.
line of identity.
and indirectly. Linear regression analysis showed a
good correlation of the two methods (r = 0.967,
p = 0.0001, y = 0.992x + 305) (fig. 1). Zinc concen-
tration median and range obtained by direct and
indirect methods were 172.8 (134.4-241.1) and 176.8
(143-243.9) μηιοΐ/ΐ erythrocytes in euthyroid subjects
and 117.1 (71-141.9) and 118.5 (73-137) μιηοΐ/ΐ
erythrocytes for hyperthyroid subjects (see fig. 2). The
values measured by the indirect method were slightly
higher in both groups. The differences of the medians
were statistically significant in the euthyroid group
(p = 0.005).
Influence of potassium EDTA
and heparinized blood on the direct zinc de-
termination in erythrocytes
In 10 persons the zinc concentration in erythrocytes
(mean ± SD) was 162.6 ± 11 μηιοΐ/ΐ for EDTA blood
and 164.8 ±14.1 μπιοΙ/1 for heparinized blood. There
was no statistically significant difference between the
values of the two groups.
Comparison of the zinc concentration in se-
rum, potassium EDTA plasma and heparin-
ized plasma
To examine differences in the zinc concentrations of
serum and plasma we determined the zinc concentra-
tions in 10 persons. Zinc concentrations (mean ± SD)
were 11.3 ± 2.8 μπιοΐ/ΐ, 11.5 ± 2.9 μιηοΐ/ΐ and 11.5
± 2.8 μιηοΐ/ΐ in serum, EDTA plasma and heparin-
as.
Euthyroid Hyperthyroid Reference
subjects subjects collective
Fig. 2. Comparison of erythrocyte zinc concentration deter-
mined by direct and indirect method in euthyroid
(n = 42) and hyperthyroid (n = 14) subjects and the
reference collective of thyroid healthy individuals
(n = 102).
e direct method, ο indirect method, median (euthyroid
and hyperthyroid group) and mean (reference collec-
tive), --- cut-off limit at 138 μιηοΐ/ΐ erythrocytes.
ized plasma, respectively. There was no statistically
significant difference between these values.
Reference values
Analysis of erythrocyte zinc concentrations in 102
subjects with normal thyroid function, using the in-
direct method, gave a concentration of 176.3 ± 23.9
μϋιοΐ/ΐ erythrocytes (mean ± SD). In the same col-
lective the serum zinc concentration was 12.2 ± 2.6
μιηοΐ/ΐ (mean ± SD). There was no significant dif-
ference between men and women. We recommend a
cut-off limit of 138 μιήοΐ/ΐ erythrocytes to hyperthy-
roidism (fig. 2).
Discussion
Zinc concentration in erythrocytes is a suitable
marker of peripheral tissue response to thyroid hor-
mones. The discrimination between short and long
term hyperthyroidism is often important for the dia-
gnosis of thyroid disease and therapy management.
Therefore determination of zinc in erythrocytes has
'become important for the routine laboratory.
Direct determination of the erythrocyte zinc concen-
tration is work intensive and time consuming. Sepa-
ration and washing procedures have to be performed
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immediately after venous puncture. The washing pro-
cedure for one sample takes about 10 minutes and
has to be performed very carefully to avoid any re-
moval of erythrocytes. On the other hand, the indirect
determination, as presented in this paper, can easily
be performed in any clinical laboratory possessing
flame atomic absorption spectrophotometry equip-
ment. Measurement of one sample by flame atomic
absorption spectrophotometry takes 30 seconds (dou-
ble determination). Serum and whole blood are di-
luted differently before analysis, so that all sample
results can be obtained from the same calibration
curve. Although complicated sample handling can be
avoided in the indirect method, it showed the same
coefficients of variation as the direct method (average
intraassay CV 1.7%, day-to-day CV 5.2%, see tab.
1). Quality control assurance is an important goal in
a clinical laboratory. For quality control of zinc de-
terminations only lyophilised reference material
(whole blood and serum) is commercially available.
Therefore only the indirect method can be checked,
and not the direct one. Analytical recovery, tested by
addition of 50 or 100 μg zinc to six different clinical
samples, averaged 100.7% for both the indirect and
the direct method. However, when the two methods
were compared by assaying 42 euthyroid and 14 hy-
perthyroid samples, the values measured by our in-
direct method were slightly higher than those meas-
ured by the direct one. In the euthyroid group this
difference was 3.1% and was statistically significant
(p == 0.005, see fig. 2), whereas in the hyperthyroid
group the difference was not statistically significant.
Data from the literature (9 — 11) for a direct method
agree with our data. In a method comparison study
in the euthyroid concentration range, Deuster et al.
(12) reported that their values from the indirect
method were 2.5% higher than those found by the
direct method. A possible explanation for this slight
difference could be the binding of membrane-bound
zinc by EDTA, which would be removed by subse-
quent washing steps. We therefore compared zinc
concentrations in washed erythrocytes from EDTA
and heparinized blood, but found no statistically sig-
nificant difference between the two values. Therefore,
it seems unlikely that considerable amounts of zinc
are removed by EDTA. Another explanation for the
slightly lower zinc concentration determined by the
direct method could be the loss of erythrocytes by the
washing procedure.
In our comparison of zinc concentrations in serum,
EDTA plasma and heparinized plasma we found no
any statistically significant differences. In studies com-
paring heparinized plasma and serum, either no dif-
ference in zinc concentrations between serum and
plasma were observed (16, 17) or a small difference
was noted (15). In the latter study slightly higher
serum values were attributed to the partial disintegra-
tion of platelets during serum clot retraction. Addi-
tionally, zinc concentration depends on the time be-
tween collection and separation of blood samples.
Unseparated, there is an increase of 6% in the zinc
concentration in serum and plasma in the first two
hours after venous puncture (15). Therefore an early
separation from cellular blood components is rec-
ommended.
To establish reference values for the presented indirect
method, we measured the erythrocyte zinc content of
102 subjects with normal thyroid function, and ob-
tained a mean value of 176.3 μιηοΐ/ΐ with an approx-
imately normal distribution of values. Assuming a
cut-off erythrocyte zinc concentration of 138 μπιοΐ/ΐ,
all but one of 102 samples had values over this limit.
All 14 hyperthyroid subjects had values below this
limit, and were therefore very well discriminated. It
is important to know that changes in erythrocyte zinc
concentration take time to develop. Patients with sud-
den onset of thyrotoxicosis due to destructive (suba-
cute or silent) thyroiditis have normal erythrocyte zinc
concentrations when they first arrive in the clinic (9).
Therefore, determination of the erythrocyte zinc con-
centration gives additional information to that ap-
proved by thyroid function tests (fT3, fT4, thyrotro-
pin), about the duration, intensity and peripheral tis-
sue response of hyperthyroidism. Further studies on
the reliability of the proposed cut-off limit in connec-
tion with other peripheral tissue markers for thyroid
hormones are in progress.
In conclusion, our paper shows that indirect deter-
mination of erythrocyte zinc concentration is an ac-
curate, reproducible and reliable method. This simple
and rapid technique is well suited for erythrocyte zinc
determination in the clinical laboratory.
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